Alban Longchamp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alban Longchamp has a total of 317 co-authors. Here are the top co-authors by number of shared publications:
- Thomas Agius
Center for Engineering in Medicine and Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
12 shared publications - Florent Allagnat
Department of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland
11 shared publications Sébastien Déglise
Department of Vascular Surgery, Lausanne University Hospital (CHUV), Lausanne, Switzerland
11 shared publicationsJean-Marc Corpataux
Department of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland
9 shared publications- Korkut Uygun
Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
9 shared publications Heidi Yeh
8 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (6)
What's Hot and What's New in Xenotransplantation From the Young Investigator Committee of the IXA–Clinical Science
The 2025 International Xenotransplantation Association (IXA) Congress in Geneva, convened in parallel with World Health Organization meetings on xenotransplantation guidance, marked a transition in clinical xenotransplantation from demonstrating that pig organs can function in humans to defining how graft injury is detected, interpreted, and managed in real time. We synthesize the major clinical themes that emerged from the meeting across kidney, heart, liver, and lung xenotransplantation. In kidney xenotransplantation, the NYU and Massachusetts General Hospital living‐recipient experiences now delineate two complementary injury patterns—antibody‐ and complement‐driven with a membranoproliferative, IgA‐positive, innate‐rich phenotype, and T cell–mediated with persistent innate immune activation—both converging on macrophage and NK‐cell biology that conventional immunosuppression does not address. The first registration‐supporting Phase 1/2/3 trial of a 10‐gene‐edited xenokidney (EXPAND) has begun, framed by IXA position‐paper recommendations and supported by recent FDA approvals. In cardiac xenotransplantation, real‐time complement‐function monitoring, global longitudinal strain, and donor‐derived cell‐free DNA emerge as an actionable surveillance toolkit, while other allotransplant biomarkers translate poorly. In liver xenotransplantation, extracorporeal cross‐circulation and the first preliminary data describing auxiliary pig‐to‐human liver transplant (171‐day survival) position porcine livers as bridge‐support platforms rather than definitive replacements. Lung xenotransplantation remains confined to ex vivo perfusion and short‐term preclinical models. Cross‐cutting priorities include donor‐pig design and individual graft phenotyping that accounts for transgene expression heterogeneity, prospectively validated multimodal monitoring, management of nephrotic‐range proteinuria and associated urinary loss of biologic immunosuppressants, and dedicated registry, ethical, and patient‐engagement infrastructure to support trustworthy clinical expansion.
- 17 November 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (6)
Open AccessWhat's Hot and What's New in Xenotransplantation From the Young Investigator Committee of the IXA–Clinical Science
The 2025 International Xenotransplantation Association (IXA) Congress in Geneva, convened in parallel with World Health Organization meetings on xenotransplantation guidance, marked a transition in clinical xenotransplantation from demonstrating that pig organs can function in humans to defining how graft injury is detected, interpreted, and managed in real time. We synthesize the major clinical themes that emerged from the meeting across kidney, heart, liver, and lung xenotransplantation. In kidney xenotransplantation, the NYU and Massachusetts General Hospital living‐recipient experiences now delineate two complementary injury patterns—antibody‐ and complement‐driven with a membranoproliferative, IgA‐positive, innate‐rich phenotype, and T cell–mediated with persistent innate immune activation—both converging on macrophage and NK‐cell biology that conventional immunosuppression does not address. The first registration‐supporting Phase 1/2/3 trial of a 10‐gene‐edited xenokidney (EXPAND) has begun, framed by IXA position‐paper recommendations and supported by recent FDA approvals. In cardiac xenotransplantation, real‐time complement‐function monitoring, global longitudinal strain, and donor‐derived cell‐free DNA emerge as an actionable surveillance toolkit, while other allotransplant biomarkers translate poorly. In liver xenotransplantation, extracorporeal cross‐circulation and the first preliminary data describing auxiliary pig‐to‐human liver transplant (171‐day survival) position porcine livers as bridge‐support platforms rather than definitive replacements. Lung xenotransplantation remains confined to ex vivo perfusion and short‐term preclinical models. Cross‐cutting priorities include donor‐pig design and individual graft phenotyping that accounts for transgene expression heterogeneity, prospectively validated multimodal monitoring, management of nephrotic‐range proteinuria and associated urinary loss of biologic immunosuppressants, and dedicated registry, ethical, and patient‐engagement infrastructure to support trustworthy clinical expansion.
- Open Access
Oxidative Stress and Apoptosis Inhibition Mitigate Static Cold Storage-Induced Injury in Liver Sinusoidal Endothelial Cells
Donor liver scarcity is exacerbated by preservation-related injury, particularly ischemia-reperfusion injury (IRI), which reduces organ utilization and increases discard rates. Liver sinusoidal endothelial cells (LSECs) play a critical role in mediating IRI, yet their response to static cold storage (SCS) remains poorly understood. Here, we investigate the impact of SCS on isolated rat LSECs. Isolated rat hepatocytes, stellate cells, Kupffer cells, and LSECs were subjected to up to 3 days of SCS followed by up to 2 days of recovery, with LSECs also receiving apoptosis and/or oxidative stress inhibition. Afterwards, changes in survivability, functionality, and morphology were measured. Additionally, changes in gene, cytokine, and chemokine expression were also measured. We found that SCS reduced cell viability by approximately 40%, accompanied by a 60% reduction in metabolic activity and ATP levels, indicating substantial impairment in cellular energetics. SCS also doubled reactive oxygen species (ROS) production and upregulated oxidative stress and apoptosis-related genes, leading to functional decline in LSECs. Importantly, combined inhibition of apoptosis and oxidative stress improved LSEC viability by 20% and metabolic activity and ATP levels by 30% and 40%, respectively, and reduced ROS production by 50%. These findings highlight LSEC vulnerability to preservation injury and the importance of understanding LSEC-specific injury mechanisms to provide a foundation for the development of endothelial-targeted preservation strategies to significantly improve liver transplantation outcomes, subsequently increasing access to this life-saving treatment.
Open AccessOxidative Stress and Apoptosis Inhibition Mitigate Static Cold Storage-Induced Injury in Liver Sinusoidal Endothelial Cells
Donor liver scarcity is exacerbated by preservation-related injury, particularly ischemia-reperfusion injury (IRI), which reduces organ utilization and increases discard rates. Liver sinusoidal endothelial cells (LSECs) play a critical role in mediating IRI, yet their response to static cold storage (SCS) remains poorly understood. Here, we investigate the impact of SCS on isolated rat LSECs. Isolated rat hepatocytes, stellate cells, Kupffer cells, and LSECs were subjected to up to 3 days of SCS followed by up to 2 days of recovery, with LSECs also receiving apoptosis and/or oxidative stress inhibition. Afterwards, changes in survivability, functionality, and morphology were measured. Additionally, changes in gene, cytokine, and chemokine expression were also measured. We found that SCS reduced cell viability by approximately 40%, accompanied by a 60% reduction in metabolic activity and ATP levels, indicating substantial impairment in cellular energetics. SCS also doubled reactive oxygen species (ROS) production and upregulated oxidative stress and apoptosis-related genes, leading to functional decline in LSECs. Importantly, combined inhibition of apoptosis and oxidative stress improved LSEC viability by 20% and metabolic activity and ATP levels by 30% and 40%, respectively, and reduced ROS production by 50%. These findings highlight LSEC vulnerability to preservation injury and the importance of understanding LSEC-specific injury mechanisms to provide a foundation for the development of endothelial-targeted preservation strategies to significantly improve liver transplantation outcomes, subsequently increasing access to this life-saving treatment.
- Open Access
- 26 June 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (7) , 449
Reduced Histidine Metabolism Is Associated with Early Allograft Dysfunction Following Liver Transplantation
Background/Objectives: Early allograft dysfunction (EAD) is a common complication after liver transplantation and is associated with inferior graft survival. While normothermic machine perfusion (NMP) has reduced EAD incidence, the prediction of early graft performance prior to implantation remains elusive. We aimed to correlate the peri-transplant energetic and metabolic profile of liver grafts with post-transplant outcome in a cohort that included grafts preserved with NMP. Methods: Sequential biopsies were taken from 20 transplanted livers (10 immediate graft function [IGF] and 10 EAD), preserved by either static cold storage or NMP. Samples were collected immediately prior to implantation and 30 min after hepatic arterial reperfusion. Untargeted liquid chromatography-mass spectrometry was performed, and energy charge was calculated as (ATP + 1/2 ADP)/(ATP + ADP + AMP). Univariate and receiver operating characteristic analysis identified metabolites correlated with EAD and assessed predictive accuracy. Results: Hepatic concentrations of adenine nucleotides and calculated energy charge did not differ between outcome groups either before implantation or after reperfusion. In contrast, trans-urocanate was significantly enriched in IGF livers across both time points, and additional histidine catabolism pathway metabolites were preferentially increased in IGF grafts. Trans-urocanate demonstrated discriminatory performance for EAD with 80% sensitivity and 80% specificity, confirmed as the single strongest predictive feature among >1600 detected metabolites. Conclusions: These data identify histidine catabolism as a novel metabolic pathway associated with early graft function and a potential indicator of allograft resilience to ischemia-reperfusion injury. Integration of histidine pathway metabolites into perfusion-era viability assessment may serve as a discriminative biomarker of EAD and support future metabolite-guided graft optimization strategies.
- 26 June 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (7) , 449
Open AccessReduced Histidine Metabolism Is Associated with Early Allograft Dysfunction Following Liver Transplantation
Background/Objectives: Early allograft dysfunction (EAD) is a common complication after liver transplantation and is associated with inferior graft survival. While normothermic machine perfusion (NMP) has reduced EAD incidence, the prediction of early graft performance prior to implantation remains elusive. We aimed to correlate the peri-transplant energetic and metabolic profile of liver grafts with post-transplant outcome in a cohort that included grafts preserved with NMP. Methods: Sequential biopsies were taken from 20 transplanted livers (10 immediate graft function [IGF] and 10 EAD), preserved by either static cold storage or NMP. Samples were collected immediately prior to implantation and 30 min after hepatic arterial reperfusion. Untargeted liquid chromatography-mass spectrometry was performed, and energy charge was calculated as (ATP + 1/2 ADP)/(ATP + ADP + AMP). Univariate and receiver operating characteristic analysis identified metabolites correlated with EAD and assessed predictive accuracy. Results: Hepatic concentrations of adenine nucleotides and calculated energy charge did not differ between outcome groups either before implantation or after reperfusion. In contrast, trans-urocanate was significantly enriched in IGF livers across both time points, and additional histidine catabolism pathway metabolites were preferentially increased in IGF grafts. Trans-urocanate demonstrated discriminatory performance for EAD with 80% sensitivity and 80% specificity, confirmed as the single strongest predictive feature among >1600 detected metabolites. Conclusions: These data identify histidine catabolism as a novel metabolic pathway associated with early graft function and a potential indicator of allograft resilience to ischemia-reperfusion injury. Integration of histidine pathway metabolites into perfusion-era viability assessment may serve as a discriminative biomarker of EAD and support future metabolite-guided graft optimization strategies.
- Open Access
- 28 May 2026
- Published by MDPI AG in Preprints.org
Reduced Histidine Metabolism Is Associated with Early Allograft Dysfunction Following Liver Transplantation
Background/Objectives: Early allograft dysfunction (EAD) is a common complication after liver transplantation and is associated with inferior graft survival While normothermic machine perfusion (NMP) has reduced EAD incidence, prediction of early graft performance prior to implantation remains elusive. We aimed to correlate peri-transplant energetic and metabolic profile of liver grafts with post-transplant outcome in a cohort that included grafts preserved with NMP. Methods: Sequential biopsies were taken from 20 transplanted livers (10 immediate graft function [IGF] and 10 EAD), preserved by either static cold storage or NMP. Samples were collected immediately prior to implantation and 30 minutes after hepatic arterial reperfusion. Untargeted liquid chromatography-mass spectrometry was performed, and energy charge was calculated as (ATP + ½ ADP)/(ATP + ADP + AMP). Univariate and receiver operating characteristic analysis identified metabolites correlated with EAD and assessed predictive accuracy. Results: Hepatic concentrations of adenine nucleotides and calculated energy charge did not differ between outcome groups either before implantation or after reperfusion. In contrast, trans-urocanate was significantly enriched in IGF livers across both time points, and additional histidine catabolism pathway metabolites were preferentially increased in IGF grafts. Trans-urocanate demonstrated discriminatory performance for EAD with 80% sensitivity and 80% specificity, confirmed as the single strongest predictive feature among >1,600 detected metabolites. Conclusions: These data identify histidine catabolism as a novel metabolic pathway associated with early graft function and a potential indicator of allograft resilience to ischemia-reperfusion injury. Integration of histidine-pathway metabolites into perfusion-era viability assessment may serve as a discriminative biomarker of EAD and support future metabolite-guided graft optimization strategies.
- 28 May 2026
- Published by MDPI AG in Preprints.org
Open AccessReduced Histidine Metabolism Is Associated with Early Allograft Dysfunction Following Liver Transplantation
Background/Objectives: Early allograft dysfunction (EAD) is a common complication after liver transplantation and is associated with inferior graft survival While normothermic machine perfusion (NMP) has reduced EAD incidence, prediction of early graft performance prior to implantation remains elusive. We aimed to correlate peri-transplant energetic and metabolic profile of liver grafts with post-transplant outcome in a cohort that included grafts preserved with NMP. Methods: Sequential biopsies were taken from 20 transplanted livers (10 immediate graft function [IGF] and 10 EAD), preserved by either static cold storage or NMP. Samples were collected immediately prior to implantation and 30 minutes after hepatic arterial reperfusion. Untargeted liquid chromatography-mass spectrometry was performed, and energy charge was calculated as (ATP + ½ ADP)/(ATP + ADP + AMP). Univariate and receiver operating characteristic analysis identified metabolites correlated with EAD and assessed predictive accuracy. Results: Hepatic concentrations of adenine nucleotides and calculated energy charge did not differ between outcome groups either before implantation or after reperfusion. In contrast, trans-urocanate was significantly enriched in IGF livers across both time points, and additional histidine catabolism pathway metabolites were preferentially increased in IGF grafts. Trans-urocanate demonstrated discriminatory performance for EAD with 80% sensitivity and 80% specificity, confirmed as the single strongest predictive feature among >1,600 detected metabolites. Conclusions: These data identify histidine catabolism as a novel metabolic pathway associated with early graft function and a potential indicator of allograft resilience to ischemia-reperfusion injury. Integration of histidine-pathway metabolites into perfusion-era viability assessment may serve as a discriminative biomarker of EAD and support future metabolite-guided graft optimization strategies.
- Open Access
- 1 May 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (3) , e70150
What's Hot and What's New in Xenotransplantation From the Young Investigator Committee of the IXA–Basic and Translational Science
Xenotransplantation has been iteratively improved over the last decade in pre‐clinical models, with first‐in‐human clinical trials underway. The 2025 IXA Congress in Geneva was held in parallel with meetings involving World Health Organization leaders to support the development of new guidance on xenotransplantation in this rapidly evolving field. Key scientific themes of the meeting included the introduction of multiple‐gene edited pigs for xenotransplantation research and clinical trials, better characterization of innate and adaptive immune responses and xenograft preservation that optimizes ramifications of ischemia‐reperfusion injury during implantation. This comes at a time when gene‐edited pig organs are being used for human xenotransplantation, a development that demands safety, reproducibility, durability, and a clear mechanistic understanding of rejection and tolerance.
- 1 May 2026
- Published by Wiley in Xenotransplantation
- Vol. 33 (3) , e70150
Open AccessWhat's Hot and What's New in Xenotransplantation From the Young Investigator Committee of the IXA–Basic and Translational Science
Xenotransplantation has been iteratively improved over the last decade in pre‐clinical models, with first‐in‐human clinical trials underway. The 2025 IXA Congress in Geneva was held in parallel with meetings involving World Health Organization leaders to support the development of new guidance on xenotransplantation in this rapidly evolving field. Key scientific themes of the meeting included the introduction of multiple‐gene edited pigs for xenotransplantation research and clinical trials, better characterization of innate and adaptive immune responses and xenograft preservation that optimizes ramifications of ischemia‐reperfusion injury during implantation. This comes at a time when gene‐edited pig organs are being used for human xenotransplantation, a development that demands safety, reproducibility, durability, and a clear mechanistic understanding of rejection and tolerance.
- 10 April 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (9) , 2111-2124
Impact of donor and recipient sex on graft function among deceased donor kidney recipients: A paired-kidney analysis
- 10 April 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (9) , 2111-2124
Impact of donor and recipient sex on graft function among deceased donor kidney recipients: A paired-kidney analysis
- Open Access
- 10 February 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (3) , e1906
Effect of Donor–Recipient Age Difference on Liver Transplant Outcomes
Background.: The global organ shortage and aging population lead to the use of liver grafts with increasing donor–recipient age discrepancies. This study evaluated the impact of donor–recipient age mismatch on posttransplant outcomes. Methods.: Organ Procurement and Transplantation Network/United Network for Organ Sharing data were analyzed, stratifying donor-to-recipient pairs by age difference: young-to-old (≥20 y), old-to-young (≥20 y), and similar-age group (P < 0.001). Patient survival did not differ significantly ( P = 0.849). A subanalysis including all liver transplants available since database inception identified 4230 livers (2.6%) reaching ≥80 y, 687 (0.4%) reaching ≥90 y, and 34 (0.02%) reaching ≥100 y. Among 188 recipients ≤35 y old who received livers from donors ≥70 y old, graft survival was inferior ( P < 0.001), and patient survival remained similar ( P = 0.271). In recipients ≤40 y old, graft survival declined incrementally with each additional donor age decade. In this subgroup, when restricted to Model for End-Stage Liver Disease ≥35, grafts from donors >60 or >70 y old showed markedly reduced 1-y survival of 81%–82%. The multivariate analysis confirmed an independent 10% increase in 1-y graft failure in the old-to-young compared with similar-age group ( P = 0.021). Conclusions.: A greater donor-to-recipient age difference, particularly with older donors, negatively impacted liver graft survival. However, patient survival was not affected, supporting the use of older grafts to optimize transplant benefits for selected recipient populations.
- 10 February 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (3) , e1906
Open AccessEffect of Donor–Recipient Age Difference on Liver Transplant Outcomes
Background.: The global organ shortage and aging population lead to the use of liver grafts with increasing donor–recipient age discrepancies. This study evaluated the impact of donor–recipient age mismatch on posttransplant outcomes. Methods.: Organ Procurement and Transplantation Network/United Network for Organ Sharing data were analyzed, stratifying donor-to-recipient pairs by age difference: young-to-old (≥20 y), old-to-young (≥20 y), and similar-age group (P < 0.001). Patient survival did not differ significantly ( P = 0.849). A subanalysis including all liver transplants available since database inception identified 4230 livers (2.6%) reaching ≥80 y, 687 (0.4%) reaching ≥90 y, and 34 (0.02%) reaching ≥100 y. Among 188 recipients ≤35 y old who received livers from donors ≥70 y old, graft survival was inferior ( P < 0.001), and patient survival remained similar ( P = 0.271). In recipients ≤40 y old, graft survival declined incrementally with each additional donor age decade. In this subgroup, when restricted to Model for End-Stage Liver Disease ≥35, grafts from donors >60 or >70 y old showed markedly reduced 1-y survival of 81%–82%. The multivariate analysis confirmed an independent 10% increase in 1-y graft failure in the old-to-young compared with similar-age group ( P = 0.021). Conclusions.: A greater donor-to-recipient age difference, particularly with older donors, negatively impacted liver graft survival. However, patient survival was not affected, supporting the use of older grafts to optimize transplant benefits for selected recipient populations.
- Open Access
- 14 January 2026
- Published by Springer Nature in Research Square
Partial Freezing Enables Functional Preservation of Kidney Grafts for up to 10 Days
Kidney transplantation is critically limited by the shortage of available donor organs, exacerbated by the discarding of viable organs due to insufficient allocation time. Here, we demonstrate the application of nature-inspired partial freezing for long-term storage of kidney grafts. We show that, after 10 days of storage, partially frozen swine and human kidneys retain improved function compared to those preserved using traditional static cold storage, as assessed via simulated transplantation.
- 14 January 2026
- Published by Springer Nature in Research Square
Open AccessPartial Freezing Enables Functional Preservation of Kidney Grafts for up to 10 Days
Kidney transplantation is critically limited by the shortage of available donor organs, exacerbated by the discarding of viable organs due to insufficient allocation time. Here, we demonstrate the application of nature-inspired partial freezing for long-term storage of kidney grafts. We show that, after 10 days of storage, partially frozen swine and human kidneys retain improved function compared to those preserved using traditional static cold storage, as assessed via simulated transplantation.
- 25 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (1) , 10-12
Subzero kidney preservation comes to scale
- 25 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (1) , 10-12
Subzero kidney preservation comes to scale
- Open Access
- 4 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (10) , 2249-2251
Emphysematous graft pancreatitis 20 years after transplant
- 4 October 2025
- Published by Elsevier in American Journal of Transplantation
- Vol. 25 (10) , 2249-2251
Open AccessEmphysematous graft pancreatitis 20 years after transplant